Jinhe Biotechnology Co.Ltd(002688)
Special report on the deposit and use of raised funds in 2021
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and are liable for false records, misleading statements or major omissions in the announcement.
1、 Basic information of raised funds
(I) amount and time of funds raised
Approved by the reply on approving Jinhe Biotechnology Co.Ltd(002688) non-public Development Bank shares (zjxk [2020] No. 3344) of China Securities Regulatory Commission, Jinhe Biotechnology Co.Ltd(002688) (hereinafter referred to as “the company” or “the company”) non publicly issued 145132743 ordinary shares (A shares), with a par value of RMB 1 per share, an issue price of RMB 5.65 per share and a total raised capital of RMB 8199999795, After deducting the issuance expenses of RMB 1775639662, the net amount of funds actually raised was RMB 80224360133. The above funds were fully paid on July 5, 2021, and were verified by ShineWing Certified Public Accountants (special general partnership) and issued the capital verification report (xyzh / 2021xaaa50306).
(II) use amount and year-end balance of raised funds in the current year
Monetary unit: RMB
Item amount remarks
The net amount of funds raised on July 5, 2021 was 80224360133
Less: 46529973595 for projects directly invested by raised funds
Less: service fee expense 146840
Less: temporary supplementary flow capital 21000000000
Plus: interest income 58562273
At the end of December 31, 2021, the raised funds were 12752801971
balance
Including: current deposit 12752801971
financial products
2、 Management of raised funds
(I) management of raised funds
In order to regulate the management and use of raised funds and protect the interests of investors, in accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the stock listing rules of Shenzhen Stock Exchange (revised in 2022), and the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board In accordance with the requirements of relevant laws, regulations and normative documents such as the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, and in combination with the actual situation of the company, the company has formulated the measures for the management of Jinhe Biotechnology Co.Ltd(002688) raised funds (hereinafter referred to as the “measures for the management of raised funds”), which has made specific and clear provisions on the supervision of the storage, use and use of raised funds, The measures for the administration of raised funds was deliberated and adopted at the 34th meeting of the second board of directors of the company on December 27, 2013. During the reporting period, the management system of raised funds was strictly implemented, the raised funds were stored in a special account, and the expenditure of raised funds projects was strictly subject to the approval procedures.
On July 30, 2021, the year of July 30, the year of the year in 2021, the year of July 30, the year of the year of the year of the year of the year of the year of the year of July 30, the year of the year of the year of the year of the year of the year of the year of the year of July 30, the year of the year of the year of the year of the year of the year of the year of the year of the year of the year of the year of the year of the year of the year of the year of the year of the year of the year of the year of the company, the sponsor, and the opening bank of the special account for funds that raise funds to raise funds and the funds of the funds of the company of the company, the company of the company of the company of the company, the company of the companies, the sponsors, the sponsor, and the opening line of the opening bank of the opening bank of the funds of the funds of the funds of the funds of the funds of the funds of the funds of the funds of the funds of the funds of the funds that) China Construction Bank Corporation(601939) Hohhot Branch (handled by China Construction Bank Corporation(601939) Hohhot Dongda sub branch) signed the tripartite supervision agreement for raised funds respectively. The company held the 20th meeting of the 5th board of directors and the 11th meeting of the 5th board of supervisors on August 12, 2021, deliberated and adopted the proposal on the company’s use of raised funds to increase capital to holding subsidiaries and implement raised investment projects, It is agreed that the company will use part of the raised funds and its own funds to increase the capital of the company’s holding subsidiaries Jinhe Youben Biological Products Co., Ltd. (hereinafter referred to as “Jinhe Youben”) and Hangzhou Youben animal vaccine Co., Ltd. (hereinafter referred to as “Hangzhou Youben”) and the implementation subject of the raised investment project. In order to standardize the management of the company’s raised funds and protect the rights and interests of small and medium-sized investors, in accordance with relevant laws and regulations and the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board and other relevant provisions, on September 2, 2021, Jinhe Youben and Hangzhou Youben, the company’s holding subsidiaries and China Merchants Bank Co.Ltd(600036) Hohhot Branch and China Minsheng Banking Corp.Ltd(600016) Hangzhou branch, the implementation subjects of the investment project with raised funds, signed the four party supervision agreement on raised funds respectively.
Since all the funds raised in the special fund-raising account opened by the company in Industrial Bank Co.Ltd(601166) Hohhot middle Hailar road sub branch and Bank Of Communications Co.Ltd(601328) Inner Mongolia Autonomous Region branch business department have been transferred to the special fund-raising account of Jinhe Youben Biological Products Co., Ltd. and Hangzhou Youben animal vaccine Co., Ltd., the funds raised in the special fund-raising account opened by the company in China Construction Bank Corporation(601939) Hohhot Dongda sub branch have been used as planned, The above three raised funds accounts are no longer used. The company has completed the cancellation procedures of the above-mentioned special raised funds account on November 5, 2021, and the tripartite supervision agreement on raised funds signed by the company with the sponsor, Industrial Bank Co.Ltd(601166) Hohhot Branch, Bank Of Communications Co.Ltd(601328) Inner Mongolia Autonomous Region branch and China Construction Bank Corporation(601939) Hohhot Branch will be terminated accordingly.
The above raised funds supervision agreement defines the rights and obligations of all parties, which is not significantly different from the model supervision agreement of Shenzhen Stock Exchange, and the responsibilities of the supervision agreement were performed well during the reporting period.
(II) storage of raised funds in special account
As of December 31, 2021, the specific deposit of raised funds is as follows:
Monetary unit: RMB
Deposit bank account number type balance remarks
China Minsheng Banking Corp.Ltd(600016) Hohhot Branch 6331428452770257927
Business department
China Merchants Bank Co.Ltd(600036) Hohhot Branch 471901636103335954524884
Business department
China Minsheng Banking Corp.Ltd(600016) Hangzhou Xiasha sub branch 6333441514028019160
China China Construction Bank Corporation(601939) Co., Ltd. 1505017066930 Weichai Power Co.Ltd(000338) 3 cancellation of Hohhot Dongda sub branch
Bank Of Communications Co.Ltd(601328) Inner Mongolia Autonomous Region 15100017901 Jiangsu Xiuqiang Glasswork Co.Ltd(300160) 76 cancellation of branch business department
Industrial Bank Co.Ltd(601166) Hohhot Haila 592140101 Luoniushan Co.Ltd(000735) 52 cancellation of Erzhong road sub branch
Total 12752801971
3、 Actual use of raised funds this year
Unit: RMB 10000
The total amount of raised funds is 8022436, and the total amount of raised funds invested in this year is 4652998
Total amount of raised funds with changed purposes during the reporting period-
Accumulated total raised funds with changed purposes – accumulated total raised funds invested 4652998
Proportion of total raised funds with accumulative change of purpose-
The total investment amount of the current year after the adjustment of the commitment investment project and the fund-raising commitment of whether the project has exceeded the changed project is accumulated by the end of the period. Whether the project has reached the expected investment progress by the end of the period and whether the project has reached the investment target of the project feasibility fund-raising in the current year (including part of the total amount of variable investment (1) (2) (%) (3) = (2) / (1) It is determined that the benefits realized by the state of availability will change greatly by the expected date
Committed investment projects
Animal vaccine production base no 3701668370166814091351409135 38.07 – not applicable not applicable no
Construction project (phase I)
New version GMP compliance no 11848031184803783162783162 66.10 – not applicable not applicable no
technical improvement project
Production process system consumption reduction no 556113556113 871.73 871.73 15.68 – not applicable not applicable no
Efficiency improvement project
Power system energy saving upgrade no 305429305429 980.94 980.94 32.12 – not applicable not applicable no
technical improvement project
Supplementary working capital no 2274423227442322754342275434 100.04 – not applicable not applicable no
Subtotal of committed investment projects 8022436802243646529984652998
There are no situations and reasons why the over raised funds have not reached the planned progress or expected income when invested in the company (1) the animal vaccine production base construction project (phase I) is still in the construction period due to the covid-19 epidemic, and has not reached the usable state for the time being
After the completion of the project, the expected internal rate of return (after income tax) is 21.71%; (2) The new GMP compliant technical transformation project is an overall technical transformation project, its income and profit are not calculated separately, and it does not involve expected income; (3) The transformation project of reducing consumption and increasing efficiency of production process system is a technical transformation project, its income and profit are not calculated separately, and it does not involve expected income; (4) The power system energy-saving upgrading technical transformation project is a technical transformation project, its income and profit are not calculated separately, and it does not involve the expected income.
The description of major changes in the feasibility of the project is not applicable
The change of the implementation location of the project invested by raised funds is not applicable
The adjustment of the implementation mode of the project invested by raised funds is not applicable
In order to ensure the smooth progress of the raised investment projects, the company has invested in the raised investment projects with self raised funds in advance before the funds raised are actually in place. As of July 5, 2021, the company has accumulated
